from Global Health Program

Health-care Provision and Health-care Reform in Post-Mao China

April 03, 2014

Testimony
Testimony by CFR fellows and experts before Congress.

More on:

China

Health

An effective strategy to engage China's health-care sector requires the U.S. government to continue promoting business opportunities for U.S. biopharmaceutical firms, hospital groups, and insurance companies, CFR Senior Fellow for Global Health Yanzhong Huang tells the U.S.-China Economic and Security Review Commission. In the meantime, it is also important for the U.S. government and companies to demonstrate the willingness to work with China in addressing health issues of their immediate concern.

More on:

China

Health

Top Stories on CFR

Saudi Arabia

The United States should pressure MBS to act with greater restraint in Yemen and elsewhere.

United Kingdom

A second Brexit vote remains the best option in a dizzyingly difficult situation.

Immigration and Migration

Ted Alden joins Jim Lindsay to discuss trade and immigration policy after the Congressional midterms.